Showing 6,119 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Resistance

WHO: Pretreatment HIV drug resistance exceeds 10% in many places

Editor's pick
Healio
24 July 2019
Treatment-experienced people

AIDS Conference Returns to Mexico City, Where We Saw an Underrated, Great Advance in HIV Therapy

Editor's pick
NEJM Journal Watch
24 July 2019
Injectable & long-acting PrEP

PrEP implant could last well over a year

News
24 July 2019
Side effects

Dolutegravir leads to weight gain in two African studies

News
23 July 2019
New & experimental HIV treatments

2019 Pipeline Report

Editor's pick
TAG
23 July 2019
Injectable & long-acting HIV treatment

People with HIV express high satisfaction with monthly injectable regimen

News
23 July 2019
Treatment guidelines

Dolutegravir recommended for all in new World Health Organization guidelines

News
23 July 2019
Child developmental issues

Dolutegravir safety in pregnancy: risk is lower than first reported

News
23 July 2019
The search for a cure

Beyond antibodies: conference hears of new molecular tools to kill HIV-infected reservoir cells

News
22 July 2019
Women

The New Face of HIV and Treating the 'Hardly Reached'

Editor's pick
Medscape (requires free registration)
20 July 2019
The search for a cure

How can researchers reduce risks to sexual partners in studies involving treatment interruptions?

News
20 July 2019
The search for a cure

Is It Safe to Interrupt HIV Treatment During Cure Studies?

Editor's pick
POZ
17 July 2019
Retention & linkage to care

Adults with HIV who have compassionate care providers start and remain in treatment longer

Editor's pick
ScienceDaily
15 July 2019
Injectable & long-acting HIV treatment

ViiV Healthcare announces start of first-ever study to identify and evaluate approaches to implementing its once-monthly injectable HIV treatment in clinical practice

Editor's pick
ViiV Healthcare press release
11 July 2019
Kidney problems

Analysis Backs New Tenofovir’s Kidney Safety Over Old Version

Editor's pick
POZ
11 July 2019
Pharmaceutical industry

GSK touts new Dovato switching data. Is it enough to shake Gilead's HIV lead?

Editor's pick
FiercePharma
11 July 2019
Injectable & long-acting HIV treatment

Lyndra Therapeutics and Gilead Sciences to Collaborate on Development of Ultra-Long-Acting HIV Therapeutics

Editor's pick
Lyndra Therapeutics press release
10 July 2019
Starting treatment

Starting ART at a high CD4 cell count has clear benefits for people with a low viral load

News
10 July 2019
Transgender people

What the Trans Community Needs to Know About New Expert Recommendations

Editor's pick
The Body
8 July 2019
Changing treatment

Drug-Resistance Mutations May Curb Efficacy of Dolutegravir-Based Regimens in Zimbabwe Teens With HIV

Editor's pick
Medscape (free registration required)
7 July 2019
Global health targets

WHO’s “Treat All” Policy Had Immediate Effect on Global HIV Treatment Rates

Editor's pick
POZ
4 July 2019
Mental & emotional health problems

One in five Americans living with HIV experience severe anxiety on an almost daily basis

News
4 July 2019
The search for a cure

Have mice really been cured of HIV using CRISPR gene editing?

Editor's pick
New Scientist
3 July 2019
How HIV works

HIV eliminated from the genomes of living animals

Editor's pick
Eurekalert Inf Dis
3 July 2019